General Information of the Compound
| Compound ID |
CP0558378
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(5R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-3-oxo-17-[(2R)-2,6,6-trimethyloxan-2-yl]-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-yl] 2-(5-phenyltetrazol-1-yl)acetate
Show/Hide
|
||||||||||||||||||
| Formula |
C39H56N4O4
|
||||||||||||||||||
| Molecular Weight |
644.901
|
||||||||||||||||||
| Canonical SMILES |
C[C@@]12CC[C@@H]([C@H]1[C@@H](C[C@@H]1[C@@]3(C)CCC(=O)C(C)(C)[C@@H]3CC[C@@]21C)OC(=O)Cn1nnnc1-c1ccccc1)[C@@]1(C)CCCC(C)(C)O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H56N4O4/c1-34(2)18-12-19-39(8,47-34)26-15-21-38(7)32(26)27(46-31(45)24-43-33(40-41-42-43)25-13-10-9-11-14-25)23-29-36(5)20-17-30(44)35(3,4)28(36)16-22-37(29,38)6/h9-11,13-14,26-29,32H,12,15-24H2,1-8H3/t26-,27+,28-,29+,32-,36-,37+,38+,39+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
KPGDPLSWNUGWBB-OUVAQKMOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound